172 related articles for article (PubMed ID: 22089093)
21. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
[TBL] [Abstract][Full Text] [Related]
23. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
24. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?
Heeringa P; Huugen D; Tervaert JW
Trends Immunol; 2005 Nov; 26(11):561-4. PubMed ID: 16139567
[TBL] [Abstract][Full Text] [Related]
25. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.
Popa ER; Franssen CF; Limburg PC; Huitema MG; Kallenberg CG; Tervaert JW
Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874
[TBL] [Abstract][Full Text] [Related]
26. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
27. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis.
Nachman PH; Reisner HM; Yang JJ; Jennette JC; Falk RJ
Lab Invest; 1996 Feb; 74(2):519-27. PubMed ID: 8780169
[TBL] [Abstract][Full Text] [Related]
28. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
29. Contribution of myeloperoxidase in vasculitis development.
Suzuki K; Okazaki T
Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of ANCA-associated vasculitis: An update.
Jarrot PA; Kaplanski G
Autoimmun Rev; 2016 Jul; 15(7):704-13. PubMed ID: 26970490
[TBL] [Abstract][Full Text] [Related]
31. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
32. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
Reynolds WF; Stegeman CA; Tervaert JW
Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models.
Huugen D; Tervaert JW; Heeringa P
Curr Opin Rheumatol; 2004 Jan; 16(1):4-8. PubMed ID: 14673382
[TBL] [Abstract][Full Text] [Related]
34. ANCA: associated lung fibrosis.
Yamada H
Semin Respir Crit Care Med; 2011 Jun; 32(3):322-7. PubMed ID: 21674417
[TBL] [Abstract][Full Text] [Related]
35. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
Malenica B; Rudolf M; Kozmar A
Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
[TBL] [Abstract][Full Text] [Related]
36. Otolaryngologic manifestations of antineutrophil cytoplasmic antibody-associated vasculitis.
Nakamaru Y; Takagi D; Oridate N; Homma A; Fukuda S
Otolaryngol Head Neck Surg; 2012 Jan; 146(1):119-21. PubMed ID: 21987646
[TBL] [Abstract][Full Text] [Related]
37. CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.
Chang J; Eggenhuizen P; O'Sullivan KM; Alikhan MA; Holdsworth SR; Ooi JD; Kitching AR
J Am Soc Nephrol; 2017 Jan; 28(1):47-55. PubMed ID: 27288012
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis and potential targets for biologic treatment.
Sanders JS; Abdulahad WH; Stegeman CA; Kallenberg CG
Nephron Clin Pract; 2014; 128(3-4):216-23. PubMed ID: 25401277
[TBL] [Abstract][Full Text] [Related]
39. No association of G-463A myeloperoxidase gene polymorphism with MPO-ANCA-associated vasculitis.
Fiebeler A; Borgmann S; Woywodt A; Haller H; Haubitz M
Nephrol Dial Transplant; 2004 Apr; 19(4):969-71. PubMed ID: 15031357
[TBL] [Abstract][Full Text] [Related]
40. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
